LEADS BIOLABS-B (09887) Authorizes Trustee to Acquire Up to $50 Million Worth of H Shares Under Incentive Plan

Stock News05-20 19:20

LEADS BIOLABS-B (09887) has announced that the company has instructed the trustee to utilize plan funds, with a total maximum amount of $50 million, to acquire additional H shares through open market transactions at prevailing market prices, in accordance with the rules of the H Share Incentive Plan. The trustee has previously, following the company's instructions and the plan rules, purchased certain H shares through the open market in 2025. The H shares targeted for acquisition in this latest instruction are intended to serve as the source of incentive shares to be granted to recipients under the H Share Incentive Plan, subject to the fulfillment of the relevant vesting conditions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment